These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13775569)

  • 21. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
    Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
    Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histology of the Mitsuda reaction of healthy adults with no known contacts with leprosy patients.
    Petri V; Mendes EV; Beiguelman B
    Int J Lepr Other Mycobact Dis; 1985 Dec; 53(4):540-5. PubMed ID: 4086917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ten-year Study of Lepromin Response in Child Contacts of Leprosy Patients.
    Ramu G
    Indian J Dermatol Venereol Leprol; 1988; 54(6):295-299. PubMed ID: 28134183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positive Mitsuda lepromin reactions in long-term treated lepromatous leprosy.
    Waters MF; Ridley DS; Lucas SB
    Lepr Rev; 1990 Dec; 61(4):347-52. PubMed ID: 2280656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immediate-type hypersensitivity response to Mitsuda lepromin component.
    Reich CV
    Int J Lepr Other Mycobact Dis; 1977; 45(4):381. PubMed ID: 564887
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study on the Mitsuda type response to antigens of chemoautotrophic nocardioform bacteria and to standard lepromin in leprosy patients.
    Chakrabarty AN; Dastidar SG; Chandra AK; Mukherjee M; Chaudhuri SK
    Acta Leprol; 1999; 11(3):105-12. PubMed ID: 10544723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lepromin retesting as a factor of lepromin test positivation.
    Azulay RD
    Int J Lepr Other Mycobact Dis; 1974; 42(4):428-30. PubMed ID: 4617721
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the lepromin reaction performed on medical students and on a control group].
    Proença NG; Farias LR; Kliemann TA; Martinez EW; Karazawa E; Guedes M; Mimica I
    Hansenol Int; 1982 Dec; 7(2):78-83. PubMed ID: 6985342
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
    Convit J; Aranzazu N; Pinardi M; Ulrich M
    Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
    Kar HK; Sharma AK; Misra RS; Zaheer SA; Mukherjee A; Mukherjee R; Beena KR; Kaur H; Nair SK; Talwar GP
    Indian J Lepr; 1992; 64(4):495-500. PubMed ID: 1308525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies in human and armadillo derived Mitsuda lepromin.
    Jesudasan K; Christian M; Chacko CJ; Keystone JS
    Lepr Rev; 1985 Dec; 56(4):303-8. PubMed ID: 4079632
    [No Abstract]   [Full Text] [Related]  

  • 32. Sensitization to lepromin induced experimentally with a vole bacillus vaccine.
    Ghosh S; Bose R
    Indian J Med Res; 1965 Nov; 53(11):1025-6. PubMed ID: 5860847
    [No Abstract]   [Full Text] [Related]  

  • 33. An in situ immunohistological study of Mitsuda reactions.
    Dugan E; Modlin RL; Rea TH
    Int J Lepr Other Mycobact Dis; 1985 Sep; 53(3):404-9. PubMed ID: 3900247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of repeated lepromin injections on the Mitsuda skin reaction.
    Beiguelman B; Quagliato R; de Camargo DP
    Int J Lepr; 1965; 33(4):795-9. PubMed ID: 5863199
    [No Abstract]   [Full Text] [Related]  

  • 35. Interaction of TaqI polymorphism at exon 9 of the vitamin D receptor gene with the negative lepromin response may favor the occurrence of leprosy.
    Goulart LR; Ferreira FR; Goulart IM
    FEMS Immunol Med Microbiol; 2006 Oct; 48(1):91-8. PubMed ID: 16965356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Mitsuda-negative leprosy patients with transfusions of whole blood from Mitsuda-positive donors.
    Almeida Gonçalves JC; Custódio J
    Lepr Rev; 1975 Mar; 46(1):15-20. PubMed ID: 1152575
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunity to leprosy and the Mitsuda reaction.
    Shepard CC
    Int J Lepr Other Mycobact Dis; 1984 Mar; 52(1):74-7. PubMed ID: 6368430
    [No Abstract]   [Full Text] [Related]  

  • 38. [Lymphocyte transformation by Mitsuda-lepromin].
    Yamada M; Fujimoto F
    Nihon Hifuka Gakkai Zasshi; 1974 Apr; 84(4):293-5. PubMed ID: 4547055
    [No Abstract]   [Full Text] [Related]  

  • 39. Histological analysis of the Mitsuda reaction in contacts of multibacillary leprosy patients.
    Trindade MA; Fleury RN
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):109-10. PubMed ID: 8326174
    [No Abstract]   [Full Text] [Related]  

  • 40. Cross reactivity of lepromin with other mycobacterial antigens.
    Goihman-Yahr M; Raffel S; Ferraresi RW
    Int J Lepr Other Mycobact Dis; 1968; 36(2):129-43. PubMed ID: 4877112
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.